Table 3.
Comparison between male and female patients with pulmonary NTM disease (N = 142)
| Characteristics | Male (N = 88, %) | Female (N = 54, %) | χ2 | P value |
|---|---|---|---|---|
| Comorbidities | ||||
| TB history | 23 (26.1) | 9 (16.7) | 1.719 | 0.219 |
| Bronchiectasis | 32 (36.4) | 15 (27.8) | 1.114 | 0.359 |
| Clinical presentations | ||||
| Cough | 82 (93.2) | 43 (79.6) | 5.832 | 0.030* |
| Haemoptysis | 33 (37.5) | 11 (20.4) | 4.592 | 0.040* |
| Laboratory investigations | ||||
| AFB smear (+) | 22 (25.0) | 12 (22.2) | 0.142 | 0.840 |
| Chest X-ray | ||||
| Fibrocavitary | 41 (46.6) | 19 (35.2) | 1.784 | 0.222 |
| Lamellar shadow | 84 (95.5) | 50 (92.6) | 0.516 | 0.479 |
| Nodule | 67 (76.1) | 44 (81.5) | 0.560 | 0.533 |
TB, tuberculosis; AFB, acid-fast bacilli.
The data are presented as number (%) unless otherwise specified; categorical variables were tested by χ2 test to assess the difference between male and female patients with pulmonary NTM disease.